Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects

NCT03599063 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer